Acheson KJ, Schutz Y, Bessard T, Anantharaman K, Flatt JP, Jéquier E (1988) Glycogen storage capacity and de novo lipogenesis during massive carbohydrate overfeeding in man. Am J Clin Nutr 48(2):240–247. https://doi.org/10.1093/ajcn/48.2.240

Article  CAS  PubMed  Google Scholar 

Ariyama H, Kono N, Matsuda S, Inoue T, Arai H (2010) Decrease in membrane phospholipid unsaturation induces unfolded protein response. J Biol Chem 285(29):22027–22035. https://doi.org/10.1074/jbc.M110.126870

Article  CAS  PubMed  PubMed Central  Google Scholar 

Asano L, Watanabe M, Ryoden Y et al (2017) Vitamin D metabolite, 25-Hydroxyvitamin D, regulates lipid metabolism by inducing degradation of SREBP/SCAP. Cell Chem Biol 24(2):207–217. https://doi.org/10.1016/j.chembiol.2016.12.017

Article  CAS  PubMed  Google Scholar 

Bansal SK, Bansal MB (2024) Pathogenesis of MASLD and MASH - role of insulin resistance and lipotoxicity. Aliment Pharmacol Ther 59(Suppl 1):S10-s22. https://doi.org/10.1111/apt.17930

Article  PubMed  Google Scholar 

Bjornson E, Mukhopadhyay B, Asplund A et al (2015) Stratification of hepatocellular carcinoma patients based on acetate utilization. Cell Rep 13(9):2014–2026. https://doi.org/10.1016/j.celrep.2015.10.045

Article  CAS  PubMed  Google Scholar 

Carli F, Della Pepa G, Sabatini S, Vidal Puig A, Gastaldelli A (2024) Lipid metabolism in MASLD and MASH: From mechanism to the clinic. JHEP Rep 6(12):101185. https://doi.org/10.1016/j.jhepr.2024.101185

Article  PubMed  PubMed Central  Google Scholar 

Chen Y, Li P (2016) Fatty acid metabolism and cancer development. Science Bulletin 61(19):1473–1479. https://doi.org/10.1007/s11434-016-1129-4

Article  CAS  Google Scholar 

Chen J, Zhou Y, Liu Z et al (2024) Hepatic glycogenesis antagonizes lipogenesis by blocking S1P via UDPG. Science (New York, NY) 383(6684):eadi3332

Article  CAS  Google Scholar 

Currie E, Schulze A, Zechner R, Walther TC, Farese RV Jr (2013) Cellular fatty acid metabolism and cancer. Cell Metab 18(2):153–161. https://doi.org/10.1016/j.cmet.2013.05.017

Article  CAS  PubMed  PubMed Central  Google Scholar 

Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ (2005) Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Investig 115(5):1343–1351. https://doi.org/10.1172/jci23621

Article  CAS  PubMed  PubMed Central  Google Scholar 

Enooku K, Nakagawa H, Fujiwara N et al (2019) Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma. Sci Rep 9(1):10663. https://doi.org/10.1038/s41598-019-47216-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Enooku K, Tsutsumi T, Kondo M et al (2020) Hepatic FATP5 expression is associated with histological progression and loss of hepatic fat in NAFLD patients. J Gastroenterol 55(2):227–243. https://doi.org/10.1007/s00535-019-01633-2

Article  PubMed  Google Scholar 

Farage AE, Abdo W, Osman A et al (2023) Betulin prevents high fat diet-induced non-alcoholic fatty liver disease by mitigating oxidative stress and upregulating Nrf2 and SIRT1 in rats. Life Sci 322:121688. https://doi.org/10.1016/j.lfs.2023.121688

Article  CAS  PubMed  Google Scholar 

Febbraio MA, Karin M (2021) “Sweet death”: Fructose as a metabolic toxin that targets the gut-liver axis. Cell Metab 33(12):2316–2328. https://doi.org/10.1016/j.cmet.2021.09.004

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fedirko V, Duarte-Salles T, Bamia C et al (2014) Prediagnostic circulating vitamin D levels and risk of hepatocellular carcinoma in European populations: a nested case-control study. Hepatology (Baltimore, MD) 60(4):1222–1230. https://doi.org/10.1002/hep.27079

Article  CAS  PubMed  Google Scholar 

Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ (2018) Mechanisms of NAFLD development and therapeutic strategies. Nat Med 24(7):908–922. https://doi.org/10.1038/s41591-018-0104-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fujiwara N, Nakagawa H (2023) Clinico-histological and molecular features of hepatocellular carcinoma from nonalcoholic fatty liver disease. Cancer Sci 114(10):3825–3833. https://doi.org/10.1111/cas.15925

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fujiwara N, Nakagawa H, Enooku K et al (2018) CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity. Gut 67(8):1493–1504. https://doi.org/10.1136/gutjnl-2017-315193

Article  CAS  PubMed  Google Scholar 

Fujiwara N, Kubota N, Crouchet E et al (2022) Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease. Sci Transl Med 14(650):eabo4474

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fujiwara N, Kimura G, Nakagawa H (2024) Emerging roles of spatial transcriptomics in liver research. Semin Liver Dis 44(2):115–132. https://doi.org/10.1055/a-2299-7880

Article  PubMed  Google Scholar 

Gosis BS, Wada S, Thorsheim C et al (2022) Inhibition of nonalcoholic fatty liver disease in mice by selective inhibition of mTORC1. Science (New York, NY) 376(6590):eabf8271

Article  CAS  Google Scholar 

Griner EM, Kazanietz MG (2007) Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer 7(4):281–294. https://doi.org/10.1038/nrc2110

Article  CAS  PubMed  Google Scholar 

Hall Z, Bond NJ, Ashmore T et al (2017) Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease. Hepatology (Baltimore, MD) 65(4):1165–1180. https://doi.org/10.1002/hep.28953

Article  CAS  PubMed  Google Scholar 

Holzer RG, Park EJ, Li N et al (2011) Saturated fatty acids induce c-Src clustering within membrane subdomains, leading to JNK activation. Cell 147(1):173–184. https://doi.org/10.1016/j.cell.2011.08.034

Article  CAS  PubMed  PubMed Central  Google Scholar 

Horie Y, Suzuki A, Kataoka E et al (2004) Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. J Clin Investig 113(12):1774–1783. https://doi.org/10.1172/jci20513

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jeon TI, Osborne TF (2012) SREBPs: metabolic integrators in physiology and metabolism. Trends Endocrinol Metab 23(2):65–72. https://doi.org/10.1016/j.tem.2011.10.004

Article  CAS  PubMed  Google Scholar 

Johnson JL, Napolitano G, Monfregola J, Rocca CJ, Cherqui S, Catz SD (2013) Upregulation of the Rab27a-dependent trafficking and secretory mechanisms improves lysosomal transport, alleviates endoplasmic reticulum stress, and reduces lysosome overload in cystinosis. Mol Cell Biol 33(15):2950–2962. https://doi.org/10.1128/mcb.00417-13

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kamisuki S, Mao Q, Abu-Elheiga L et al (2009) A small molecule that blocks fat synthesis by inhibiting the activation of SREBP. Chem Biol 16(8):882–892. https://doi.org/10.1016/j.chembiol.2009.07.007

Article  CAS  PubMed